A much-loved former swimming pool and leisure centre at the heart of a Merseyside housing estate looks set to be demolished within months. Woodchurch Leisure Centre in Wirral closed its doors for the ...
Democratic and Republican leaders remain far apart on how to end the partial shutdown of the US government as another day of voting approaches on Monday. In separate Sunday interviews with NBC's Meet ...
Join the region’s most dynamic peer-led gathering of businesses, sustainability leaders, and innovators building readiness for credible decarbonisation action. Held during Bangkok Climate Action Week, ...
SHREVEPORT, La. Local Christian and country artist Krystina Barnes has a new record deal with CDX Records, in partnership with The Orchard (Sony Music) for global distribution. This marks the next ...
PALO ALTO - Guardant Health, Inc. (NASDAQ:GH) announced Monday that the U.S. Food and Drug Administration has approved its Guardant360 CDx blood test as a companion diagnostic to identify advanced ...
This marks the second FDA-approved indication for Guardant360 CDx as a companion diagnostic in breast cancer treatment ESR1 mutations are present in 40% of HR+, HER2- advanced breast cancers “This FDA ...
The CytoCell KMT2A Breakapart FISH Probe Kit PDx is approved as a companion diagnostic for revumenib in KMT2A translocated acute leukemia. Revumenib showed a 21.2% complete remission rate in ...
The CDx System is a combination medical device consisting of the OncoGuide™ OncoScreen™ Plus CDx Kit and the OncoGuide™ OncoScreen™ Plus CDx Analysis Program, designed to be used with a ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Idylla CDx MSI test — a fully automated, “sample-to-result” companion diagnostic — for ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...
SUFFERN, NEW YORK / ACCESS Newswire / July 24, 2025 / CDx Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its proprietary ...
Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that its Idylla™ EGFR Mutation Test has received the European Union ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback